JPH0125722B2 - - Google Patents

Info

Publication number
JPH0125722B2
JPH0125722B2 JP56025058A JP2505881A JPH0125722B2 JP H0125722 B2 JPH0125722 B2 JP H0125722B2 JP 56025058 A JP56025058 A JP 56025058A JP 2505881 A JP2505881 A JP 2505881A JP H0125722 B2 JPH0125722 B2 JP H0125722B2
Authority
JP
Japan
Prior art keywords
group
benzimidazole
anthelmintic
antibiotics
salicylamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56025058A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57139012A (en
Inventor
Kunitoshi Kitano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12155318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH0125722(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to JP56025058A priority Critical patent/JPS57139012A/ja
Priority to DE2002199008 priority patent/DE10299008I2/de
Priority to GB8204765A priority patent/GB2093695B/en
Priority to DE8282300829T priority patent/DE3260921D1/de
Priority to EP82300829A priority patent/EP0059074B1/en
Priority to IE369/82A priority patent/IE52364B1/en
Priority to ZA821135A priority patent/ZA821135B/xx
Priority to US06/350,641 priority patent/US4468390A/en
Priority to AU80711/82A priority patent/AU552403B2/en
Priority to NZ199817A priority patent/NZ199817A/en
Publication of JPS57139012A publication Critical patent/JPS57139012A/ja
Publication of JPH0125722B2 publication Critical patent/JPH0125722B2/ja
Priority to NL300082C priority patent/NL300082I1/nl
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56025058A 1981-02-23 1981-02-23 Anthelmintic composition Granted JPS57139012A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP56025058A JPS57139012A (en) 1981-02-23 1981-02-23 Anthelmintic composition
DE2002199008 DE10299008I2 (de) 1981-02-23 1982-02-18 Anthelmintische Zusammensetzung un ihre Verwendung.
GB8204765A GB2093695B (en) 1981-02-23 1982-02-18 Anthelmintic composition containing macrolide antibiotics
DE8282300829T DE3260921D1 (en) 1981-02-23 1982-02-18 Anthelmintic composition and the use thereof
EP82300829A EP0059074B1 (en) 1981-02-23 1982-02-18 Anthelmintic composition and the use thereof
US06/350,641 US4468390A (en) 1981-02-23 1982-02-22 Anthelmintic composition and the use thereof
ZA821135A ZA821135B (en) 1981-02-23 1982-02-22 Anthelmintic composition and the use thereof
IE369/82A IE52364B1 (en) 1981-02-23 1982-02-22 Anthelmintic composition and the use thereof
AU80711/82A AU552403B2 (en) 1981-02-23 1982-02-23 Anthelmintic composition and use
NZ199817A NZ199817A (en) 1981-02-23 1982-02-23 Anthelmintic composition consisting of two components
NL300082C NL300082I1 (nl) 1981-02-23 2002-02-13 Anthelmintische samenstelling en het gebruik daarvan.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56025058A JPS57139012A (en) 1981-02-23 1981-02-23 Anthelmintic composition

Publications (2)

Publication Number Publication Date
JPS57139012A JPS57139012A (en) 1982-08-27
JPH0125722B2 true JPH0125722B2 (2) 1989-05-19

Family

ID=12155318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56025058A Granted JPS57139012A (en) 1981-02-23 1981-02-23 Anthelmintic composition

Country Status (10)

Country Link
US (1) US4468390A (2)
EP (1) EP0059074B1 (2)
JP (1) JPS57139012A (2)
AU (1) AU552403B2 (2)
DE (2) DE10299008I2 (2)
GB (1) GB2093695B (2)
IE (1) IE52364B1 (2)
NL (1) NL300082I1 (2)
NZ (1) NZ199817A (2)
ZA (1) ZA821135B (2)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426333B1 (en) * 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
FR2753377B1 (fr) * 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
MA19678A1 (fr) * 1982-01-13 1983-10-01 Ciba Geigy Ag Agents anti-helmintiques.
DE3410348A1 (de) * 1984-03-21 1985-10-03 Helmut Dr. Bozen Schwienbacher Verfahren zur bekaempfung von fischmykosen und mittel zur durchfuehrung des verfahrens
DE3784520D1 (de) * 1986-01-25 1993-04-08 Hoechst Ag Schaedlingsbekaempfungsmittel.
GB9024924D0 (en) * 1990-11-16 1991-01-02 Beecham Group Plc Novel compositions
AU2003236405B2 (en) * 1999-04-14 2007-10-25 Merial Ltd Anthelmintic Composition
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
AU691990B2 (en) * 1994-11-28 1998-05-28 Virbac S.A. Equine anthelmintic formulations
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
FR2739778B1 (fr) * 1995-10-13 1997-12-12 Virbac Lab Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal
WO1997046204A2 (en) 1996-06-05 1997-12-11 Ashmont Holdings Limited Injectable compositions
DE19654079A1 (de) 1996-12-23 1998-06-25 Bayer Ag Endo-ekto-parasitizide Mittel
ES2359973T3 (es) 1998-03-19 2011-05-30 MERCK SHARP & DOHME CORP. Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US20040077703A1 (en) * 2002-10-02 2004-04-22 Soll Mark D. Nodulisporic acid derivative spot-on formulations for combating parasites
PT1610613T (pt) * 2003-04-04 2017-03-07 Merial Inc Formulações veterinárias anti-helmínticas tópicas
JP4734498B2 (ja) * 2003-07-09 2011-07-27 ライフ テクノロジーズ コーポレイション タンパク質−タンパク質相互作用を解析する方法
US7396819B2 (en) 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
US7671034B2 (en) * 2003-12-19 2010-03-02 Merial Limited Stabilized formulation of ivermectin feed premix with an extended shelf life
WO2005094210A2 (en) 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
WO2005099692A1 (en) * 2004-04-07 2005-10-27 Intervet International B.V Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use
GB0508993D0 (en) * 2005-05-03 2005-06-08 Syngenta Participations Ag Pesticidal compositions
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
EP2465851A1 (en) 2006-07-05 2012-06-20 Aventis Agriculture 1-Aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
US7919522B2 (en) * 2007-05-03 2011-04-05 Merial Limited Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds
RS55271B1 (sr) 2007-05-15 2017-02-28 Merial Sas Ariloazol-2-il cijanoetilamino jedinjenja, postupci dobijanja i postupci njihove primene
WO2009070687A1 (en) 2007-11-26 2009-06-04 Merial Limited Solvent systems for pour-on formulations for combating parasites
ES2617672T3 (es) 2008-10-08 2017-06-19 Zoetis Services Llc Composiciones antihelmínticas de bencimidazol
AR074024A1 (es) 2008-11-14 2010-12-15 Merial Ltd Compuesto de arilazol-2-il-cianoetilamino enantiomericamente enriquecidos, composicion plaguicida y su uso para prevenir la infeccion parasitaria
MY155497A (en) 2008-11-19 2015-10-30 Merial Inc Compositions comprising an aryl pyrazole and/or a formamidine, methods and use thereof
AP2909A (en) 2009-03-17 2014-05-31 Concert Pharmaceuticals Inc Pyrazinoisoquinoline Compounds
CN102712583B (zh) 2009-12-04 2015-04-08 梅里亚有限公司 农药用双-有机硫化合物
RS54772B1 (sr) 2009-12-17 2016-10-31 Merial Sas Antiparazitska jedinjenja dihidroazola i kompozicije koje ih sadrže
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
US8822528B2 (en) 2010-11-16 2014-09-02 Merial Limited Monensin derivatives for the treatment and prevention of protozoal infections
US20120329832A1 (en) 2011-06-27 2012-12-27 Jean Delaveau Novel Insect-Repellent Coumarin Derivatives, Syntheses, and Methods of Use
ES2618813T3 (es) 2011-06-27 2017-06-22 Merial, Inc. Compuestos y composiciones de éter amido-piridílico y uso contra los parásitos
RS58417B1 (sr) 2011-09-12 2019-04-30 Merial Inc Paraziticidne kompozicije koje sadrže izoksazolinsko aktivno sredstvo, postupci i upotrebe povezane sa njima
WO2013044118A2 (en) 2011-09-23 2013-03-28 Merial Limited Indirect modeling of new repellent molecules active against insects, acarids, and other arthropods
AU2012340351B2 (en) 2011-11-17 2017-06-15 Boehringer Ingelheim Animal Health USA Inc. Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof
EP3216448B8 (en) 2012-02-06 2019-06-05 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
BR122015032741B1 (pt) 2012-04-20 2019-11-26 Merial Ltd composições parasiticídicas compreendendo derivados de benzimidazol, métodos e seus usos
NZ723198A (en) 2012-11-20 2018-11-30 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic compounds and compositions and methods of using thereof
EP2950795B1 (en) 2013-01-31 2018-04-25 Merial, Inc. Method for treating and curing leishmaniosis using fexinindazole
WO2015066277A1 (en) 2013-11-01 2015-05-07 Merial Limited Antiparisitic and pesticidal isoxazoline compounds
EP3131398B1 (en) 2014-04-17 2019-10-23 Boehringer Ingelheim Animal Health USA Inc. Use of malononitrile compounds for protecting animals from parasites
ES2842592T3 (es) 2014-05-19 2021-07-14 Boehringer Ingelheim Animal Health Usa Inc Compuestos antihelmínticos
EP3157912B1 (en) 2014-06-19 2019-02-20 Merial, Inc. Parasiticidal compositions comprising indole derivatives, methods and uses thereof
US10864193B2 (en) 2014-10-31 2020-12-15 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising fipronil at high concentrations
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
SG11201708068PA (en) 2015-04-08 2017-10-30 Merial Inc Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
LT3298027T (lt) 2015-05-20 2021-08-10 Boehringer Ingelheim Animal Health USA Inc. Antihelmintiniai depsipeptido junginiai
WO2016191389A2 (en) 2015-05-27 2016-12-01 Merial, Inc. Compositions containing antimicrobial igy antibodies, for treatment and prevention of disorders and diseases caused by oral health compromising (ohc) microorganisms
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
WO2018071535A1 (en) 2016-10-14 2018-04-19 Merial, Inc. Pesticidal and parasiticidal vinyl isoxazoline compounds
CA3044038A1 (en) 2016-11-16 2018-05-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
WO2019005700A1 (en) 2017-06-26 2019-01-03 Merial, Inc. DOUBLE-ACTING PARASITICIDE GRANULATE COMPOSITIONS, METHODS AND USES THEREOF
BR112020003217A2 (pt) 2017-08-14 2020-10-06 Boehringer Ingelheim Animal Health USA Inc. compostos pesticidas e parasiticidas de pirazolisoxazolina
EP3749096A1 (en) 2018-02-08 2020-12-16 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
AU2019301510B2 (en) 2018-07-09 2024-06-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anthelminthic heterocyclic compounds
CN113260419A (zh) 2018-11-20 2021-08-13 勃林格殷格翰动物保健美国公司 吲唑基氰基乙基氨基化合物、其组合物、其制备方法和其使用方法
NZ776819A (en) 2019-01-16 2023-04-28 Boehringer Ingelheim Animal Health Usa Inc Topical compositions comprising a neonicotinoid and a macrocyclic lactone, methods and uses thereof
AU2020231319A1 (en) 2019-03-01 2021-10-21 Boehringer Ingelheim Animal Health USA Inc. Injectable clorsulon compositions, methods and uses thereof
CA3133100A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
BR112022000982A2 (pt) 2019-07-22 2022-03-08 Intervet Int Bv Forma de dosagem veterinária mastigável macia
KR20230028268A (ko) 2020-05-29 2023-02-28 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 헤테로시클릭 화합물
WO2022140728A1 (en) 2020-12-21 2022-06-30 Boehringer Ingelheim Animam Health Usa Inc. Parasiticidal collar comprising isoxazoline compounds
WO2025257633A1 (en) 2024-06-12 2025-12-18 Boehringer Ingelheim Vetmedica Gmbh Long-acting castor oil-containing injectable formulations and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914624A (2) * 1972-06-08 1974-02-08
PH15982A (en) * 1977-10-03 1983-05-18 Merck & Co Inc Selective hydrogenation producta of c-076 compounds and derivatives thereof
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4203976A (en) * 1978-08-02 1980-05-20 Merck & Co., Inc. Sugar derivatives of C-076 compounds
US4289760A (en) * 1980-05-02 1981-09-15 Merck & Co., Inc. 23-Keto derivatives of C-076 compounds

Also Published As

Publication number Publication date
DE10299008I2 (de) 2004-10-21
DE10299008I1 (de) 2002-07-04
US4468390A (en) 1984-08-28
EP0059074A1 (en) 1982-09-01
GB2093695B (en) 1984-03-28
EP0059074B1 (en) 1984-10-10
AU8071182A (en) 1982-09-02
GB2093695A (en) 1982-09-08
ZA821135B (en) 1983-02-23
NL300082I1 (nl) 2002-04-02
IE820369L (en) 1982-08-23
DE3260921D1 (en) 1984-11-15
NZ199817A (en) 1984-12-14
AU552403B2 (en) 1986-05-29
JPS57139012A (en) 1982-08-27
IE52364B1 (en) 1987-09-30

Similar Documents

Publication Publication Date Title
JPH0125722B2 (2)
Finlay et al. Viomycin, a new antibiotic active against mycobacteria
CN108699052B (zh) 驱虫缩酚酸肽化合物
Rood et al. Isolation and characterization of multiply antibiotic-resistant Clostridium perfringens strains from porcine feces
Girard et al. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution
CN107835818B (zh) 驱虫缩酚酸肽化合物
DE69633734T2 (de) Antibakterielle nitroimidazolverbindungen und verfahren zu deren verwendung
DE68920673T2 (de) 13-Substituierte Milbemycinderivate, ihre Herstellung und Verwendung.
AU2009308180B2 (en) Methods for treating gastrointestinal diseases
RS54904B1 (sr) Antibakterijske farmaceutske kompozicije
Hirano et al. Structure–activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents
Sanfilippo et al. Biological activity of a new class of rifamycins Spiro-piperidyl-rifamycins
AU658268B2 (en) Antiparasitic avermectin and milbemycin derivatives
WO2005007143A2 (en) Use of makrolides and ketolides for the treatment of tuberculosis
EP0222186B1 (en) Erythromycin derivatives /a
JP2837957B2 (ja) 駆虫薬
DE60025370T2 (de) 9a-azalide mit antibakterieller wirkung
DE60133273T2 (de) Inhibitoren von peptid deformylase
DE60112280T2 (de) Inhibitoren von peptid-deformylase
EP0213692A2 (en) Use of hygromycin and epihygromycin in the treatment of swine dysentery
Muri et al. Anti-Helicobacter pylori agents. An update
Woodruff et al. The antibiotics explosion
US9308215B2 (en) Avermectins and milbemycins as anti-mycobacterial agents
CN104177373A (zh) 抗结核化合物imb-cc223
CN110981888A (zh) N-芳基二硫吡咯酮脲类和氨基酯类衍生物及其制备和应用